Cargando…

544. Pharmacokinetic Profile of Ibalizumab From a Phase 3 Trial

BACKGROUND: Ibalizumab (IBA) is a long-acting humanized monoclonal antibody that binds domain 2 of the CD4 receptor and blocks HIV-1 infection of host cells. TMB-301 was a 24-week, Phase 3 clinical trial conducted in 40 heavily treatment-experienced patients with multidrug-resistant (MDR) HIV-1 inve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Princy N, Weinheimer, Steven, Cohen, Zvi, Marsolais, Christian, Kuo, Kuei-Ling, Lewis, Stanley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255274/ http://dx.doi.org/10.1093/ofid/ofy210.552

Ejemplares similares

Forty-eight-Week Safety and Efficacy On-Treatment Analysis of Ibalizumab in Patients with Multi-Drug Resistant HIV-1
por: Emu, Brinda, et al.
Publicado: (2017)

1008. Disease Severity Impact on Long-Term Virologic Response to Ibalizumab in Expanded Access Protocol (TMB-311)
por: Kumar, Princy, et al.
Publicado: (2020)

661. Ibalizumab Efficacy and Safety Through 48 Weeks of Treatment: Results of an Expanded Access Protocol (TMB-311)
por: Emu, Brinda, et al.
Publicado: (2019)

Efficacy, Pharmacokinetics, and Safety Over 48 Weeks With Ibalizumab-Based Therapy in Treatment-Experienced Adults Infected With HIV-1: A Phase 2a Study
por: Gathe, Joseph C., et al.
Publicado: (2021)

1027. Long-Term Efficacy, Safety, and Durability of Ibalizumab-Based Regimens in Subgroup of TMB-202 Participants
por: Towner, William, et al.
Publicado: (2020)

Ibalizumab: First Global Approval
por: Markham, Anthony
Publicado: (2018)

2494. Real-World Use of Ibalizumab in Physician Office Infusion Centers (POICs)
por: Prokesch, Richard C, et al.
Publicado: (2019)

2493. Real-World Utilization of Ibalizumab (IBA) Without an Optimized Background Regimen (OBT)
por: Bouchard, Jeannette, et al.
Publicado: (2019)

Correction to: Ibalizumab: First Global Approval
por: Markham, Anthony
Publicado: (2018)

Ibalizumab Targeting CD4 Receptors, An Emerging Molecule in HIV Therapy
por: Iacob, Simona A., et al.
Publicado: (2017)

544. Outpatient Remdesivir Use at a Stand Alone Children's Hospital
por: Rodriguez, Brittany, et al.
Publicado: (2023)

Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc
por: Rose, Ronald, et al.
Publicado: (2022)

Reactivation of Hepatitis B After Ibalizumab Therapy for Multidrug-Resistant Human Immunodeficiency Virus
por: Kaplan, Alyson, et al.
Publicado: (2021)

544. Severe COVID-19 in Children and Young Adults in the Washington DC Metropolitan Region
por: DeBiasi, Roberta L, et al.
Publicado: (2020)

PT544. The effect of acoustic white noise on motor learning and correlation with neural activity in an animal model of ADHD.
por: Eckernäs, Daniel, et al.
Publicado: (2016)

544 Clinical Features of Patients with Ataxia-Telangiectasia at Reference Center in Sao Paulo, Brazil
por: Matos, Josemar, et al.
Publicado: (2012)

FRI544 Serological Profile In Rheumatoid Arthritis And Its Interplay With Autoimmune Thyroid Diseases
por: Kolitz, Tamara, et al.
Publicado: (2023)

Draft Genome Sequence of Brucella abortus Virulent Strain 544
por: Singh, D. K., et al.
Publicado: (2015)

544. Using Active Surveillance to Identify Monoclonal Antibody Candidates Among COVID-19 Positive Veterans, Atlanta VA Healthcare System
por: Paras, Alexander T, et al.
Publicado: (2021)

544. Clonal Spread of Two Sequence Types of Carbapenem-Resistant Acinetobacter baumannii Blood Isolates at a Tertiary Care Hospital in South Korea Over 2.5 Years
por: Eun Kim, Seong, et al.
Publicado: (2019)

Preludes and fugues BWV 544, 541, 546, 542 and 536
por: Bach, Johann Sebastian, 1685-1750
Publicado: (1992)

Bactericidal Effect of Silver Nanoparticles on Intramacrophage Brucella abortus 544
por: Alizadeh, Hamed, et al.
Publicado: (2014)

SUN-544 A Not-So-Poetic Case of Abdominal Distension
por: Ellard, Karolina, et al.
Publicado: (2019)

544 Creating Communities for Burn Survivors Using Metaverse Platform
por: Hwang, Se-Hee
Publicado: (2023)

SUN-544 Immunologic Effects of GLP-1 Activation in Obese Adipose Tissue
por: Mashayekhi, Mona, et al.
Publicado: (2020)

SAT544 Abnormal Labs Reveal Metastatic Papillary Thyroid Cancer
por: Shahid, Muhammad, et al.
Publicado: (2023)

2529. Population pharmacokinetic models for cefepime and enmetazobactam derived from pooled Phase 1 to Phase 3 clinical studies
por: Vollmer, Jannik, et al.
Publicado: (2023)

1340. Population Pharmacokinetic (PK) Analysis of APX001 Using Phase 1 Data
por: Trang, Michael, et al.
Publicado: (2018)

Flow decorrelations in 5.44 TeV Xe+Xe collisions in ATLAS
por: Behera, Arabinda
Publicado: (2019)

SAT-544 Primary Aldosteronism in Intracerebral Hemorrhage. Not Intracerebral Hemorrhage in Primary Aldosteronism
por: Arai, Makoto, et al.
Publicado: (2020)

1701. Pharmacokinetics in Subjects with Renal Impairment in a Contezolid Complicated Skin and Soft Tissue Infection Phase 3 Clinical Trial
por: Fang, Edward, et al.
Publicado: (2022)

2561. Population Pharmacokinetic Analyses for Ceftobiprole Using Data from Phase 1 and 3 Studies
por: Cammarata, Anthony P, et al.
Publicado: (2023)

Multi-Drug-resistant Organism (MDRO) Infections in Liver Transplant Recipients 30 Days Post-Transplant
por: Parpia, Tarina, et al.
Publicado: (2017)

Pharmacokinetic-Pharmacodynamic Target Attainment Analysis to Support VL-2397 Dose Selection for a Phase 2 Trial in Patients with Invasive Aspergillosis
por: Rubino, Christopher M, et al.
Publicado: (2017)

1586. Phase 3/3b Experience with Long-Acting Cabotegravir and Rilpivirine: Efficacy and Safety Outcomes Through Week 96 by Race
por: Patel, Parul, et al.
Publicado: (2022)

Premian record transmision de datos a 5,44 gigabits por segundo
Publicado: (2003)

Measurement of the analyzing power in $pp$ elastic scattering at 439 and 544 MeV/c
por: Perrot-Kunne, F, et al.
Publicado: (1991)

Molecular cloning, purification and immunogenicity of recombinant Brucella abortus 544 malate dehydrogenase protein
por: Reyes, Alisha Wehdnesday Bernardo, et al.
Publicado: (2016)

Human MiR-544a Modulates SELK Expression in Hepatocarcinoma Cell Lines
por: Potenza, Nicoletta, et al.
Publicado: (2016)

Azelaic Acid Induces Mitochondrial Biogenesis in Skeletal Muscle by Activation of Olfactory Receptor 544
por: Thach, Trung Thanh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bq827lernljg3lgmlfgecbeq4h